BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 7686510)

  • 1. Effects of specific zidovudine resistance mutations and substrate structure on nucleotide-dependent primer unblocking by human immunodeficiency virus type 1 reverse transcriptase.
    Meyer PR; Matsuura SE; Tolun AA; Pfeifer I; So AG; Mellors JW; Scott WA
    Antimicrob Agents Chemother; 2002 May; 46(5):1540-5. PubMed ID: 11959594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N1,N3-disubstituted uracils as nonnucleoside inhibitors of HIV-1 reverse transcriptase.
    Novikov MS; Valuev-Elliston VT; Babkov DA; Paramonova MP; Ivanov AV; Gavryushov SA; Khandazhinskaya AL; Kochetkov SN; Pannecouque C; Andrei G; Snoeck R; Balzarini J; Seley-Radtke KL
    Bioorg Med Chem; 2013 Mar; 21(5):1150-8. PubMed ID: 23357038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-[2-(2-Benzoyl- and 2-benzylphenoxy)ethyl]uracils as potent anti-HIV-1 agents.
    Novikov MS; Ivanova ON; Ivanov AV; Ozerov AA; Valuev-Elliston VT; Temburnikar K; Gurskaya GV; Kochetkov SN; Pannecouque C; Balzarini J; Seley-Radtke KL
    Bioorg Med Chem; 2011 Oct; 19(19):5794-802. PubMed ID: 21903401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deoxyribonucleotide-containing RNAs: a novel class of templates for HIV-1 reverse transcriptase.
    Gudima SO; Kazantseva EG; Kostyuk DA; Shchaveleva IL; Grishchenko OI; Memelova LV; Kochetkov SN
    Nucleic Acids Res; 1997 Nov; 25(22):4614-8. PubMed ID: 9358173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of nucleoside analog antiviral activity and resistance during human immunodeficiency virus reverse transcription.
    Arts EJ; Wainberg MA
    Antimicrob Agents Chemother; 1996 Mar; 40(3):527-40. PubMed ID: 8851566
    [No Abstract]   [Full Text] [Related]  

  • 6. Site-directed mutagenesis of HIV reverse transcriptase to probe enzyme processivity and drug binding.
    Beard WA; Wilson SH
    Curr Opin Biotechnol; 1994 Aug; 5(4):414-21. PubMed ID: 7520785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity of HIV-1 reverse transcriptase and its mutants to inhibition by azidothymidine triphosphate.
    Carroll SS; Geib J; Olsen DB; Stahlhut M; Shafer JA; Kuo LC
    Biochemistry; 1994 Mar; 33(8):2113-20. PubMed ID: 7509634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzymatic characterization of human immunodeficiency virus type 1 reverse transcriptase resistant to multiple 2',3'-dideoxynucleoside 5'-triphosphates.
    Ueno T; Shirasaka T; Mitsuya H
    J Biol Chem; 1995 Oct; 270(40):23605-11. PubMed ID: 7559526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleoside drug resistance in HIV-1 reverse transcriptase.
    Yadav PN; Yadav JS; Modak MJ
    Nat Struct Biol; 1995 Mar; 2(3):193-5. PubMed ID: 7539709
    [No Abstract]   [Full Text] [Related]  

  • 10. Enzymatic properties of two mutants of reverse transcriptase of human immunodeficiency virus type 1 (tyrosine 181-->isoleucine and tyrosine 188-->leucine), resistant to nonnucleoside inhibitors.
    Loya S; Bakhanashvili M; Tal R; Hughes SH; Boyer PL; Hizi A
    AIDS Res Hum Retroviruses; 1994 Aug; 10(8):939-46. PubMed ID: 7529032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced binding of azidothymidine-resistant human immunodeficiency virus 1 reverse transcriptase to the 3'-azido-3'-deoxythymidine 5'-monophosphate-terminated primer.
    Canard B; Sarfati SR; Richardson CC
    J Biol Chem; 1998 Jun; 273(23):14596-604. PubMed ID: 9603976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of the HIV-1 reverse transcriptase 'AZT-resistant' mutant with substrates and AZT-TP.
    Pokholok DK; Gudima SO; Yesipov DS; Dobrynin VN; Rechinsky VO; Kochetkov SN
    FEBS Lett; 1993 Jul; 325(3):237-41. PubMed ID: 7686510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of HIV-1 reverse transcriptase and fidelity of in vitro DNA replication.
    Abbotts J; Wilson SH
    J Enzyme Inhib; 1992; 6(1):35-46. PubMed ID: 1285301
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.